≡

Multiplex Assay Kit for Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD243; ABCB1; ABC20; CLCS; GP170; MDR1; PGY1; P-Glycoprotein; Multidrug resistance protein 1; ATP-Binding Cassette,Sub-Family B(MDR/TAP),Member 1; Colchicin Sensitivity

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 85-92 88
EDTA plasma(n=5) 97-104 101
heparin plasma(n=5) 97-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 96-105% 83-90% 98-105% 92-102%
EDTA plasma(n=5) 82-99% 84-94% 92-101% 92-99%
heparin plasma(n=5) 82-101% 84-95% 80-95% 83-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:Pgp) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Forum of Allergy & Rhinology P-glycoprotein promotes epithelial T helper 2–associated cytokine secretion in chronic sinusitis with nasal polyps Onlinelibrary: alr.21316
International Forum of Allergy & Rhinology P‐glycoprotein regulates Staphylococcus aureus enterotoxin B–stimulated interleukin‐5 and thymic stromal lymphopoietin secretion in organotypic mucosal explants PubMed: 26625351
American Journal of Rhinology & Allergy Intact soluble P-glycoprotein is secreted by sinonasal epithelial cells. pubmed:27456593
The Laryngoscope Secreted P-glycoprotein is a noninvasive biomarker of chronic rhinosinusitis pubmed:27577924
Materials Science and Engineering: C Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia
Molecular Cancer Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance Pubmed: 31830995
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB690Ra01 Recombinant Permeability Glycoprotein (Pgp) Positive Control; Immunogen; SDS-PAGE; WB.
PAB690Ra01 Polyclonal Antibody to Permeability Glycoprotein (Pgp) WB; IHC; ICC; IP.
SEB690Ra ELISA Kit for Permeability Glycoprotein (Pgp) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB690Ra Multiplex Assay Kit for Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.